Filing Flows › NovoCure (NVCR) › Recalls, complaints & regulation
NovoCure (NVCR): clinical trials
NovoCure (NVCR) beyond its filings: 4 active clinical trials.
NovoCure's latest quarter
NovoCure, Q3 2026: revenue $193M (+16% year over year), operating margin -3.2%, net loss $10.4M, operating cash flow $22.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does NovoCure have?
4 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.